| NAVN |
Navan, Inc. |
AH Equity Partners V (Parallel), L.L.C. |
10% Owner
|
2026-01-06 |
P - A |
308,188 |
16.74 |
5,159,067.12 |
8,300,455 |
| NAVN |
Navan, Inc. |
AH Equity Partners V (Parallel), L.L.C. |
10% Owner
|
2026-01-06 |
P - A |
308,188 |
16.74 |
5,159,067.12 |
8,300,455 |
| NAVN |
Navan, Inc. |
AH Equity Partners V (Parallel), L.L.C. |
10% Owner
|
2026-01-06 |
P - A |
308,188 |
16.74 |
5,159,067.12 |
8,300,455 |
| NAVN |
Navan, Inc. |
AH Equity Partners V (Parallel), L.L.C. |
10% Owner
|
2026-01-06 |
P - A |
308,188 |
16.74 |
5,159,067.12 |
8,300,455 |
| NAVN |
Navan, Inc. |
AH Equity Partners V (Parallel), L.L.C. |
10% Owner
|
2026-01-06 |
P - A |
308,188 |
16.74 |
5,159,067.12 |
8,300,455 |
| ACN |
Accenture plc |
Unruch Joel |
Officer
|
2026-01-06 |
S - D |
1,332 |
275.00 |
366,300.00 |
28,207 |
| ALHC |
Alignment Healthcare, Inc. |
Maroney Dawn Christine |
Officer
|
2026-01-06 |
S - D |
228,152 |
21.33 |
4,867,600.10 |
1,057,015 |
| ALHC |
Alignment Healthcare, Inc. |
Kim Hyong |
Officer
|
2026-01-06 |
S - D |
16,506 |
21.35 |
352,356.88 |
333,133 |
| HL |
HECLA MINING CO/DE/ |
Allen Kurt |
Officer
|
2026-01-06 |
S - D |
9,560 |
22.00 |
210,352.50 |
259,300 |
| HL |
HECLA MINING CO/DE/ |
Allen Kurt |
Officer
|
2026-01-06 |
S - D |
42,659 |
21.89 |
933,656.20 |
216,641 |
| HL |
HECLA MINING CO/DE/ |
Allen Kurt |
Officer
|
2026-01-06 |
J - A |
23,774 |
0.00 |
0.00 |
23,774 |
| MRSN |
Mersana Therapeutics, Inc. |
Alleva Lawrence M |
Director
|
2026-01-06 |
U - D |
578 |
0.00 |
0.00 |
0 |
| MRSN |
Mersana Therapeutics, Inc. |
Alleva Lawrence M |
Director
|
2026-01-06 |
U - D |
84 |
0.00 |
0.00 |
0 |
| MRSN |
Mersana Therapeutics, Inc. |
Alleva Lawrence M |
Director
|
2026-01-06 |
D - D |
2,460 |
0.00 |
0.00 |
0 |
| MRSN |
Mersana Therapeutics, Inc. |
Alleva Lawrence M |
Director
|
2026-01-06 |
D - D |
800 |
0.00 |
0.00 |
0 |
| MRSN |
Mersana Therapeutics, Inc. |
Alleva Lawrence M |
Director
|
2026-01-06 |
D - D |
142 |
0.00 |
0.00 |
0 |
| MRSN |
Mersana Therapeutics, Inc. |
Alleva Lawrence M |
Director
|
2026-01-06 |
D - D |
400 |
0.00 |
0.00 |
0 |
| MRSN |
Mersana Therapeutics, Inc. |
Alleva Lawrence M |
Director
|
2026-01-06 |
D - D |
544 |
0.00 |
0.00 |
0 |
| MRSN |
Mersana Therapeutics, Inc. |
Alleva Lawrence M |
Director
|
2026-01-06 |
D - D |
1,000 |
0.00 |
0.00 |
0 |
| MRSN |
Mersana Therapeutics, Inc. |
Alleva Lawrence M |
Director
|
2026-01-06 |
D - D |
450 |
0.00 |
0.00 |
0 |
| MRSN |
Mersana Therapeutics, Inc. |
Alleva Lawrence M |
Director
|
2026-01-06 |
D - D |
368 |
0.00 |
0.00 |
0 |
| MRSN |
Mersana Therapeutics, Inc. |
Alleva Lawrence M |
Director
|
2026-01-06 |
D - D |
133 |
0.00 |
0.00 |
0 |
| MRSN |
Mersana Therapeutics, Inc. |
Alleva Lawrence M |
Director
|
2026-01-06 |
D - D |
1,002 |
0.00 |
0.00 |
0 |
| MRSN |
Mersana Therapeutics, Inc. |
Alleva Lawrence M |
Director
|
2026-01-06 |
D - D |
546 |
0.00 |
0.00 |
0 |
| MRSN |
Mersana Therapeutics, Inc. |
Alleva Lawrence M |
Director
|
2026-01-06 |
D - D |
1,800 |
0.00 |
0.00 |
0 |